Capital Flow Monitor · Sponsors · CIK 1593437
Junto Capital Partners LP
550 MADISON AVENUE, NEW YORK, NY, 10022 · 212-409-1906
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$3.36B
% sold
—
Investors
251
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | D/A ·current | 506(b) | — | $3.36B | — | 251 | EDGAR ↗ |
| 2025-09-12 | D/A | 506(b) | — | $2.69B | — | 234 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- - Junto Capital Partners GP LLC — Executive Officer, New York, NY
-
James Parsons — Executive Officer, New York, NY
2 other raises
- Junto Capital Affiliates LP $1.4M of —
- Sernova Biotherapeutics Inc. $345K of $843K · 40.9%
-
N/A Junto Capital Management LP — Promoter, New York, NY
3 other raises
- Junto Offshore Fund Ltd. $3.53B of —
- Junto Offshore Fund II Ltd. $692.4M of —
- Junto Capital Affiliates LP $1.4M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.